Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Atreca Inc Cl A (NQ: BCEL )

0.9981 +0.0111 (+1.12%)
Streaming Delayed Price Updated: 4:00 PM EDT, Jun 2, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 79,318
Open 0.9900
Bid (Size) 0.9981 (1)
Ask (Size) 1.170 (1)
Prev. Close 0.9870
Today's Range 0.9764 - 1.010
52wk Range 0.7595 - 2.795
Shares Outstanding 39,092,167
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Recap: Atreca Q1 Earnings
 
Via Benzinga
Atreca Reports First Quarter 2023 Financial Results and Recent Corporate Developments
From Atreca, Inc.
Via GlobeNewswire

Performance

YTD
+9.09%
+9.09%
1 Month
+5.04%
+5.04%
3 Month
-32.10%
-32.10%
6 Month
-4.03%
-4.03%
1 Year
-36.02%
-36.02%

More News

Read More
Atreca Announces Oral Presentation of ATRC-101 Phase 1b Study Data at ASCO 2023 Annual Meeting
From Atreca, Inc.
Via GlobeNewswire
Atreca to Participate in the Canaccord Genuity Horizons in Oncology Virtual Conference
From Atreca, Inc.
Via GlobeNewswire
The Latest Analyst Ratings for Atreca
Via Benzinga
Preview: Atreca's Earnings
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For March 30, 2023
Via Benzinga
Philip Morris To Rally Over 22%? Here Are 10 Other Analyst Forecasts For Thursday
Via Benzinga
Atreca Reports Fourth Quarter and Full-Year 2022 Financial Results and ATRC-101 Data Update
From Atreca, Inc.
Via GlobeNewswire
Atreca to Host Fourth Quarter and Year End 2022 Conference Call and Webcast on March 29, 2023
From Atreca, Inc.
Via GlobeNewswire
Atreca to Participate at Cowen’s 43rd Annual Health Care Conference
From Atreca, Inc.
Via GlobeNewswire
Why Is T2 Biosystems (TTOO) Stock Down 21% Today?
Via InvestorPlace
Why Is Atreca (BCEL) Stock Up Today?
Via InvestorPlace
Why Fusion Pharmaceuticals Shares Are Trading Higher By 23%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
Atreca and Xencor to Develop T Cell Engaging Bispecific Antibody Directed Against Novel Solid Tumor Target
From Atreca, Inc.
Via GlobeNewswire
Atreca Appoints Philippe Bishop, MD as Chief Medical Officer
From Atreca, Inc.
Via GlobeNewswire
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
After Bill Gates Dumps Billions In Berkshire To Buy Microsoft, His Quiet Biotech Portfolio Has Made A New Trade
Via Benzinga
12 Health Care Stocks Moving In Thursday's After-Market Session
Via Benzinga
Benzinga's Top Ratings Upgrades, Downgrades For January 5, 2023
Via Benzinga
Stocks That Hit 52-Week Lows On Friday
Via Benzinga
Why Inotiv Shares Dipped 57%; Here Are 76 Biggest Movers From Yesterday
Via Benzinga
Atreca Reports Third Quarter 2022 Financial Results and Provides Pipeline Update
From Atreca, Inc.
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.